Atlas Trials

Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis

Clinical trial NCT06146972 · UNKNOWN

Trial details

NCT number
NCT06146972
Sponsor
Yanfeng Hou
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Rheumatoid ArthritisTherapy
Start date
2021-06-01
Primary completion
2024-03-24
Enrollment
117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.